Aerovate Therapeutics, Inc. Contracts & Agreements
36 Contracts & Agreements
- Business Finance (5 contracts)
- Business Operations (3)
- Human Resources (11)
- Intellectual Property (2)
- Real Estate (4)
- Uncategorized (11)
- Cell Line License Agreement, effective October 22, 2024, by and between WuXi Biologics Ireland Limited and Jade Biosciences, Inc (Filed With SEC on December 3, 2024)
- Jade Biosciences, Inc. Amended and Restated 2024 Equity Incentive Plan and the Form of Stock Option Agreement thereunder (Filed With SEC on December 3, 2024)
- Form of Restricted Stock Purchase Agreement (Filed With SEC on December 3, 2024)
- Offer Letter between Jade Biosciences, Inc. and Tom Frohlich, dated as of August 20, 2024 (Filed With SEC on December 3, 2024)
- Offer Letter between Jade Biosciences, Inc. and Jonathan Quick, dated as of August 29, 2024 (Filed With SEC on December 3, 2024)
- Offer Letter between Jade Biosciences, Inc. and Andrew King, dated as of July 31, 2024 (Filed With SEC on December 3, 2024)
- Offer Letter between Jade Biosciences, Inc. and Hetal Kocinsky, dated as of September 3, 2024 (Filed With SEC on December 3, 2024)
- Offer Letter between Jade Biosciences, Inc. and Elizabeth Balta, dated as of October 21, 2024 (Filed With SEC on December 3, 2024)
- Antibody Discovery and Option agreement, dated July 24, 2024, by and between Paragon Therapeutics, Inc., Parade Biosciences Holding, LLC and Jade Biosciences, Inc (Filed With SEC on December 3, 2024)
- Amendment No. 1 to Antibody Discovery and Option Agreement, dated as of September 27, 2024 (Filed With SEC on December 3, 2024)
- Biologics Master Services Agreement, effective July 10, 2024, by and between WuXi Biologics (Hong Kong) Limited) and Jade Biosciences, Inc (Filed With SEC on December 3, 2024)
- APRIL License Agreement, dated October 30, 2024, by and between Paragon Therapeutics, Inc. and Jade Biosciences, Inc (Filed With SEC on December 3, 2024)
- Separation and Release Agreement, by and between the Registrant and Timothy Pigot, dated August 15, 2024 (Filed With SEC on November 12, 2024)
- Lease Amendment, dated January 2, 2024, by and between the Registrant and PDM 930 Unit, LLC (Filed With SEC on May 13, 2024)
- Lease, Amendment, dated January 2, 2024, by and between the Registrant and PDM 930 Unit, LLC (Filed With SEC on March 25, 2024)
- Compensation Recovery Policy (Filed With SEC on August 14, 2023)
- ATM Equity OfferingSM Sales Agreement, dated as of April 5, 2023, by and between Aerovate Therapeutics, Inc. and BofA Securities, Inc (Filed With SEC on April 5, 2023)
- Lease, dated April 26, 2022, by and between the Registrant and Hudson Metro Center, LLC (Filed With SEC on April 29, 2022)
- Description of Securities (Filed With SEC on March 30, 2022)
- Lease, dated August 6, 2021, by and between the Registrant and PDM 930 Unit, LLC (Filed With SEC on August 12, 2021)
- Employment Agreement between the Registrant and Ralph Niven, to be in effect upon the closing of this offering (Filed With SEC on June 25, 2021)
- Employment Agreement between the Registrant and Hunter Gillies, to be in effect upon the closing of this offering (Filed With SEC on June 25, 2021)
- Employment Agreement between the Registrant and Benjamin T. Dake, to be in effect upon the closing of this offering (Filed With SEC on June 25, 2021)
- Form of Underwriting Agreement (Filed With SEC on June 24, 2021)
- Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (Filed With SEC on June 17, 2021)
- Form of Specimen Common Stock Certificate (Filed With SEC on June 17, 2021)
- 2021 Stock Option and Incentive Plan, and form of award agreements thereunder (Filed With SEC on June 17, 2021)
- 2021 Employee Stock Purchase Plan (Filed With SEC on June 17, 2021)
- Non-Employee Director Compensation Policy (Filed With SEC on June 17, 2021)
- Form of Amended and Restated Employment Agreement (Filed With SEC on June 17, 2021)
- Senior Executive Cash Incentive Bonus Plan (Filed With SEC on June 17, 2021)
- Investors Rights Agreement among the Registrant and certain of its stockholders, dated August 5, 2020 (Filed With SEC on June 9, 2021)
- Offer Letter between the Registrant and Ralph Niven, dated April 26, 2020 (Filed With SEC on June 9, 2021)
- Offer Letter between the Registrant and Hunter Gillies, dated April 27, 2020 (Filed With SEC on June 9, 2021)
- Offer Letter between the Registrant and Benjamin T. Dake, dated November 4, 2019 (Filed With SEC on June 9, 2021)
- 2018 Equity Incentive Plan, and form of award agreements thereunder (Filed With SEC on June 9, 2021)
